Christina Annunziata
From Wikipedia, the free encyclopedia
Christina Annunziata | |
|---|---|
 | |
| Alma mater | Georgetown University Medical School (MD, PhD) |
| Scientific career | |
| Fields | Medical oncology |
| Institutions | National Cancer Institute, American Cancer Society |
| Thesis | CD40 signaling Hodgkin's disease (2000) |
Christina Messineo Annunziata is an American medical oncologist researching molecular signal transduction in ovarian cancer. She is Senior Vice President, Extramural Discovery Science at the American Cancer Society, and volunteers in the National Cancer Institute's women's malignancies branch.
Annunziata is a graduate of Georgetown University Medical School where she also completed graduate school and residency training in internal medicine.[1] Her dissertation was titled CD40 signaling Hodgkin's disease.[2]
She came to the National Cancer Institute (NCI) as a postdoctoral researcher for medical oncology training in the medical oncology branch. Annunziata joined the NCI laboratory of Louis M. Staudt in the metabolism branch to investigate NF-kappaB signaling in multiple myeloma. She returned to the medical oncology branch to extend her study of these molecular pathways in the ovarian cancer model.[1][3] She researched in the clinic of Elise C. Kohn.[4]
